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Abstract 
Objective: Menopause might lead to physical, mental problems for women and also disruption theirlife 
quality. Despite the existance of a single treatment to remove the disorders, herbal medicine is referable to 
chemical one in that they alleviate the related symptoms. The present research study aims to investigate the effect 
of Hypericum Perforatum L. on severity of early symptoms of menopause. Materials and Method: This double 
blind clinical trial study was conducted on 70 menopause women (two 35-person groups) picked out by a 
purposive sampling procedure. The first group received 160 mg Hypericum Perforatum L. (Perforin pill) while the 
second one received a placebo (ineffective pill). Menopause symptoms of 2, 4, 6, and 8 weeks after taking the pill 
or placebo were recorded in the 'Kupperman index' for menopause symptoms. The gathered data were then 
analyzed via independent t-test, one-way ANOVA, and repeated measure variance. Significance level was P≤0.05. 
Results: The age average in the medicine group was 50.49±2. 74 and in the placebo group was 50.63±2.87. Body 
Mass Index (BMI) showed an overweight in both groups (27.29±0.75, 27.23±0.64). Furthermore, comparing the 
'Kupperman index'for symptoms between the two groups in 6, 4, and 8 weeks after intervention revealed that the 
Hypericum Perforatum L. significantly had positive effects on alleviation of eraly menopause symptoms compared 
to placebo (P≤0.001).  Conclusion: The results indicated that Hypericum Perforatum L. might alleviate the severity 
of early menopause symptoms. Thus, given its being economical and also its slight side effects, it is recommended 
as a suitable and desirable replacement for counterpart chemical medicine.  
Keywords: Menopuase, Hypericum Perforatum  L., 'Kupperman index. 
*Corresponding Author: 
Alieh Etemadi Kermani,  
Master of Midwifery,  
Ahvaz Jundishapur University of Medical Sciences, 
Ahvaz, Iran.        
Email: alieh..a@yahoo.com   
Introduction 
The transition from fertility to menopause is a 
phenomenon that all women experience throughout the 
world (1). This physiological phenomenon is an 
important stage in the life of women, which is followed 
by the loss of the activity of the follicles of the ovaries 
and the reduction of female sex hormones (estrogen), 
menstrual cycles are completely discontinued (2) and 
gradually the fertility And eventually the person faces a 
new biological condition (3). 
There is a difference between menopause in 
different societies. This difference depends on many 
factors and factors, such as the extent to which 
countries, races, and their social and economic status 
develop and develop (4). 
The statistics and information available for the 
growing and increasing number of postmenopausal 
women in the whole world are projected to reach 1.11 
billion by the year 2025 (1). 
Although menopause is a natural phase of 
women's lives, many are a distressing period that 
experiences many problems before and after, often 
resulting in reduced health due to symptoms. (5,6). One 
of the symptoms that women experience during 
menopause include sleep disorders, mood disorders, 
genitourinary disorders (such as urgency in urination, 
dyspnea and vaginal atrophy and painful intercourse), 
vasomotor disorders (such as hot flushes), Night sweats 
and palpitations), joint pain and stiffness, forgetfulness 
and increased risk of osteoporosis and hair loss (7-12). 
The severity of the symptoms experienced in 
postmenopausal women is different, in such a way that a 
woman may not experience any of the symptoms, or 
only experience one or more or even all of the 
symptoms. Some people may experience severe 
symptoms and vice versa, others may have only mild 
symptoms. In addition, the severity of symptoms in one 
person may also vary in different days. According to 
these cases, it is impossible to predict menopause 
symptoms and to cure the treatment (13), and ultimately 
pressure the health care system and impose significant 
costs on them (14). ) Therefore, any attempt to maintain 
and promote the health of postmenopausal women will 
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have a beneficial effect on reducing health costs (15).  
Currently, menopausal disorders and 
complications are typically treated and controlled by 
methods such as hormone therapy, including the use of 
synthetic estrogen (16) but due to the complications of 
hormone therapy (increased risk) of vascular events and 
breast cancer) and concerns about these complications; 
the long-term admission of this therapeutic approach is 
low (17) and ultimately leads to a reduction in the use of 
this method and the switch to alternative therapies to 
relieve menopausal symptoms (18).  
Some studies have shown that about 32.9% of 
women in the world have switched to complementary 
medicine, of which about half of them use 
complementary medicine solely to treat menopausal 
symptoms (19). Medicinal plants are widely used today 
to prevent and treat various types of disorders and 
diseases, and every day human knowledge is added to 
the identification, the mechanisms of exposure and the 
ingredients involved in the manufacture of herbal 
medicines. One of the plants that today is considered by 
many due to its numerous properties and much research 
on it and is one of the most widely used herbal remedies 
in the whole world; it is Hypericum Perforatum L.   or 
tea grass (20). This herb is a perennial herb and 
wilderness, with yellow flowers that are similar to the 
vegetable parts of the plant. This plant is native to the 
regions of Europe, West Asia and North Africa (21) .The 
plant contains various compounds and chemicals, 
including anthraquinone derivatives (naphthodentrons), 
flavonoids, tannins, some phenols, fluoroquinolones, 
volatile oils, hyperfluorine and hypressinum. The 
industrial preparations of this plant are based on the two 
substances of Hypericin and Pseudo-Hypericin (22). The 
results of study by Caning et al. Indicated that flowering 
plants were significantly more effective than placebo in 
improving the behavioral and physical symptoms of 
premenstrual syndrome (23) .Volker and colleagues in 
their study showed that combination therapy of black 
cohosh with grass is beneficial for the improvement of 
mental symptoms and hot flashes in postmenopausal 
women (24). 
With life expectancy increase, women spend 
almost one third of their life in menopause period. 
Causing problems such as mental and physical disorders, 
menopause is likely to threaten the health of family and 
society, which is, in turn, dependent on mothers' health. 
Thus, it is essential to pay special attention to the health 
of menopause women. Since there is no complete and 
single treatment for removing these problems, different 
researchers have tried to examine the effects of various 
chemical and herbal medicines. However, given the 
country's research priorities in terms of herbal medicine 
and limited studies in this regard and also given 
contractor results in Farsi and Latin articles, the present 
study tried to examine the impact of Hypericum 
Perforatum L.  on early symptoms of menopause. 
  
Materials and Methods  
The present research study is a double blind 
clinical trial with an ethics permission from Ahwaz 
medical sciences university numbered U-88221 and 
clinical trial record number of 
IRCT2016040820053N2R1. The study was conducted 
on 70 menopausal women who referred to treatment-
hygienic centers in 2009 in Izeh county. The criteria to 
enter into the study were: age of 45-60 years old, 
amenorrhea for at least 12 months, having at least two 
signs of menopause based on Kooperman's index, and 
having literacy. Besides, from among criteria to exclude 
from the study were: women suffering from unnatural 
menopausal symptoms that is, cessation of menstruation 
resulted from hysterectomy and radiotherapy, known 
systematic diseases such as endocrine disorders 
(thyrotoxicosis), abundant use of phytostrogens and 
specific diet in general, having known physical or 
mental disease, using sexual hormones, allergy to herbal 
plants, athlete women, using anti-depression medicine, 
using herbal medicine, BMI higher than 30, and 
immigration of under study units. The sample size was 
determined to be 70 by considering the previous related 
studies and also statistics experts' comments via the 
following formula:     
 
 
The sampling procedure was based on purposive 
sampling and then the research units were assigned 
randomly in two 35-person groups of control and 
experimental. First, the purpose of the study was 
explained to all the units and their informed written 
consent was received. They were also assured that in 
case they had any sudden intolerable side effect or 
became unwilling to continue the study, they could stop 
taking part in the study. All in all, 80 persons started the 
study. However, at the beginning of the study 10 of 
them exited the study due to lack of willingness to 
participate in the study and the study was conducted on 
70 persons. 
Intended data were gathered via 'Kupperman 
index'for menopauasal symptoms and also 
demographical questionnaire. The former is a scale that 
examines the most important symptoms of menopause. 
This scale has been used for more than 50 years in 
different studies related to menopause signs. The 
modified version of this scale that was used in the 
present study consisted of 9 important menopausal 
symptoms including hot flash, night sweat, insomnia, 
anger, depression, fatigue, headache, polyurea, and 
bladder pain. These symptoms are scored based on a 
four-degree likert scale from zero (lack of symptom) to 
three (severe) (0=no symptom, 1=slight, 2=medium, 
3=severe). To weigh the score, the score of hot flash is 
multiplied by 4, score of night sweat, insomnia, and 
anger are multiplied by 2, depression, fatigue, headache, 
polyurea, and bladder pain scores are multiplied by 1. 
The maximum score of the scale is 45. Finally, its 
validity has already been confirmed (25). 
Blinding was done in this way that the medicine 
(Hypericum Perforatum L. in form of Perforan pill) and 
placebo were coded by another person and were put in 
similar packs in a way that neither the researcher nor the 
subjects had any information on the packs and the 
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research units selected and used one of the packs while 
referring to the centers. Both of the groups were given 
the Kooperman scale and they were asked to record the 
symptoms 2, 4, 6, and 8 weeks after using the medicine 
or placebo. The medicine and placebo were prescribed 
three times a day (one in the morning, and two in the 
afternoon with a glass of water) for two months (the 
forms and drugs were given to the units in two stages). 
The medicine included 160 mg of dried hydro-alcoholic 
extract of Hypericum Perforatum L. (in form of 
Perforan pill) that included 300 microgram of effective 
Hypericum Perforatum L.  produced by Isfahan Gol-
Daroo company in 30-number packs (26). 
The placebo pills were similar to the main 
medicine in terms of size, color, shape, weight, and 
packing. During the study time, the researcher was in 
phone contact with all of the research units to ensure 
about the exact use of drugs and if they had any 
question, she answered them. The gathered data were 
then analyzed by SPSS 13 in general and descriptive 
tests such as frequency table, mean, SD, and analytic 
tests including independent t-test, one way ANOVA, 
and repeated mesure variance in particular. Finally, the 
significance level was considered to be P≤0.05.  
 
Results 
The results of the study that was carried out on 70 
menopausal women revealed that 54.3 percent of 
women in the medicine group and 60 percent of the 
women in the placebo group were within the age range 
of 45-50 years old. 37.1 percent of the medicine group 
and 22.9 percent of the placebo group were unmarried 
and 100 percent of the two groups had lower than 
diploma degree. 57.2 percent of menopausal women in 
the medicine group and 42.9 percent of the placebo had 
severe hot flash and no significant dfference was 
observed between the two groups in terms of the above-
mentioned features (P≥0.05). Finally, the two groups 
were homogeneous in terms of age, BMI, menstruation 
cease time period, times of hot flash within 24 hours, 
and Kooperman's symptoms index (P≥0.05) (Table 1).         
 
Table 1. Demographic characteristics of Menopausal 
Women in two groups 
 
Comparison of scores gained from the 
'Kupperman index' via independent t-test in the two 
groups uncovered that there was a significant difference 
between the two groups in scores of 4, 6, and 8 weeks 
after the intervention (P≤0.001). Furthermore, the 
Group  
variable 
Placebo 
Mean & SD 
Medicine 
Mean & SD 
p-value 
Age (years) 50.63 ± 2.87 50.49 ± 2.74 0.832 
BMI 27.29 ± 0.75 27.23 ± 0.64 0.734 
Menstruation 
cease time 
(month) 
30.89 ± 12.5 28.66 ± 13.6 0.48 
Hot flash times 
in 24 hours 
4.09 ± 0.98 4.26 ± 0.98 0.467 
Kooperman 
Index 
26.37 ± 6.89 26.09 ± 6.82 0.862 
repeated measure variance results showed that time pass 
had significant impact on alleviation of the symptoms in 
the medicine group (P≤0.001) (Table 2).  
 
Table 2. Comparison of Kooperman index in 
menopausal women before and after intervention 
 
 
Discussion 
The results of this study, which was carried out 
to investigate the effect of Hypericum Perforatum L. on 
severity of early symptoms of menopause, revealed that 
Hypericum Perforatum L. had a positive impact on 
early menopause symptoms. Using three 160 mg pills 
Hypericum Perforatum L. (Perforan) daily for a two 
month time period bear significant eefect on alleviating 
the symptoms compared to the placebo. The study by 
Walker et al. also uncovered that there was a significant 
difference between the experimental ad control groups 
after using Rhymifin pill (a combination of Hypericum 
Perforatum L. and black Kohosh) compared to the time 
when only black Kohosh withought Hypericum 
Perforatum L. was used (24). Similarly, Chung et al. 
also used a combination of Hypericum Perforatum L. 
and black Kohosh in the intervention and observed a 
significant alleviation in the menopausal symptoms 
(27). The similarity of these two studies findings might 
be due to their use of 'Kupperman index' and time 
period of 4 and 8 weeks.  
In the study by Motaghi Dastenaiee et al., 
physical symptoms of menopause such as night hot 
flash, sleep problems, heart disorders, and muscle-joint 
disorders reduced significantly after four weeks while 
after two weeks there was observed no significant 
reduction in some signs (28). In a similar vein, the study 
by Salehi, the extract of Isoflavone of trifolium Pratenes 
had effects on menopause symptoms and although a 
considerable reduction in the symptoms was observed 
in the sixth week, it was not statistically significant 
(29). The findings of these studies are in line with those 
of the present study and these similarities with further 
severity might recommend that herbal medicine could 
positively help to alleviate the severity of menopausal 
symptoms (30). As the studies findings indicate, as time 
passed by, the scores of the 'Kupperman index' 
decreased meaning that menopausal symptoms reduce 
with use of Hypericum Perforatum L. . 
The study by Abbasian et al., in which the effect 
of Perforan (Hypericum Perforatum L. ) on temperature 
signs of pre-menstrual syndrome was examined, 
showed that using Hypericum Perforatum L.  
significantly reduce anger, depression, unreasonable 
crying, and feeling of lonliness. The present study also 
Group 
Time 
Medicine 
Mean & SD 
Placebo 
Mean & SD 
p-
value 
Before 
the study 
26.09 ± 6.82 26.37 ± 6.89 0.862 
Week 2 25.49 ± 6.65 26.33 ± 6.97 0.565 
Week 4 18.31 ± 6.78 26.26 ± 7.44 0.001 
Week 6 9.06 ± 6.21 26.11 ± 7.02 0.001 
Week 8 6.49 ± 4.61 26.06 ± 7.02 0.001 
p-value <0.001 0.12   
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showed that as he above-mentioned symptoms reduced, 
the 'Kupperman index'scores also decreased. PMS that 
starts a few days before the next one, is typically 
followed by reduction of Strogen secretion that is the 
main factor for this syndrome. This is also one reason 
for comparing the effect of Hypericum Perforatum L.  
on PMS and menopause (31). 
Alternative medicine is one of medical issues 
that is developing among experts and consumers. They 
are especially gaining wide information in terms of 
herbal medicine as it pays special attention to selection 
of treatment method. Fortunately, our country is rich in 
terms of existence of herbal plants. Hypericum 
Perforatum L.  is extant in mountains as a self growing 
plant and that is why, it has a less price in the country 
compared to other countries (32).  
From among the strengths of the present study 
are evaluation of menopause symptoms before the 
intervention stage and determining the effect of 
Hypericum Perforatum L.  in four consecutive periods 
that, in turn, helped to reach better results. Furthermore, 
from among its weak points is determination of 
effectiveness till eight weeks after using the medicine 
that given the gradual impact of Hypericum Perforatum 
L.  and other herbal plants on menopause symptoms, it 
was better to examine its effect to some weeks after that 
as well. One restriction of the study was also lack of 
equality in absorbtion of materials of the drugs in 
different persons and also their perspective toward the 
purpose of the study that affected their responding to the 
questionnaire.  
 
Conclusion 
Given the findings of the current research study, 
Hypericum Perforatum L.  is effective on alleviation of 
early symptoms of menopause. Menopause is a natural 
phenomenon in the life of women and its symptoms are 
usually painful for them. On the other hand, given the 
economical aspect of Hypericum Perforatum L., its easy 
and wide availability due to its abundance in the 
country, and more importantly, its effectiveness on 
alleviation of menopausal pains and having slight side 
effects in comparison to chemical drugs, it is 
recommended to use Hypericum Perforatum L.  as a 
suitable and effective replacement for counterpart 
chemical drugs.  
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